Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision
By: Colorado BioScience Association Date: 08/28/2023
Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision New Partnership Will Accelerate Delivery of Lab Space to Market AURORA, Colo. (August 24, 2023) – Fitzsimons Innovation...
Learn MoreGrowing Colorado’s Promising Startups: Innosphere Ventures
By: Colorado BioScience Association Date: 08/18/2023
Fort-Collins-based Innosphere Ventures began making an impact for Colorado’s early-stage companies a quarter-century ago. The organization’s focus is to support the business development of early-stage...
Learn MoreWeekly Policy Blog: PDAB Releases Stakeholder Engagement Guide on Affordability Review Process
By: Colorado BioScience Association Date: 08/14/2023
As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request thei...
Learn MoreWeekly Policy Blog: PDAB Selects Drugs for Affordability Reviews
By: Colorado BioScience Association Date: 08/07/2023
On Friday, August 4, the Colorado Prescription Drug Affordability Board (PDAB) selected five drugs for affordability reviews: Enbrel, Genvoya, Cosentyx, Stelara, and Trikafta. PDAB staff plan to begin...
Learn MoreA Pioneering Spirit: Female Leaders Advancing Innovation
By: Colorado BioScience Association Date: 08/04/2023
Making Colorado a leading location for health innovation requires visionaries, risk takers, problem solvers, and program builders. Women hold these pivotal roles in our state, guiding major institutio...
Learn MoreForging the Life Sciences Frontier
By: Colorado BioScience Association Date: 08/04/2023
Colorado has one of the best talent pools in the United States, top-tier research institutions, a major international airport, a favorable tax climate, a mountain-enhanced quality of life, and support...
Learn MoreWeekly Policy Blog: Congressional Activity Before August Recess
By: Colorado BioScience Association Date: 07/31/2023
Congress moved forward with its efforts to address drug shortages, drug pricing, pharmacy benefit managers (PBMs), and transparency ahead of the August recess. This policy post covers the discussion d...
Learn MoreFitzsimons Innovation Community - Building a Life Sciences Pipeline: Room to Grow
By: Colorado BioScience Association Date: 07/31/2023
For the past few months, the Fitzsimons Innovation Community blog has been focused on how and why Colorado is such a great home for growing life sciences organizations. This month’s topic is the benef...
Learn MoreWeekly Policy Blog: PAHPA Reauthorization Advances Without Government Price Fixing
By: Colorado BioScience Association Date: 07/24/2023
Congress took important action on pandemic preparedness last week, advancing the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bills in both the Senate and the House ahead of its e...
Learn MoreWeekly Policy Blog: Drug Pricing and Affordability Update
By: Colorado BioScience Association Date: 07/17/2023
Drug pricing and affordability continue to be key issues at both the state and federal levels as new legislation is considered and implementation of legislation that has already passed is underway....
Learn More